A PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF GLOFITAMAB IN COMBINATION WITH GEMCITABINE

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Contributors

McKinney, Matthew Stuart Principal Investigator

Start/End

December 8, 2021 - December 30, 2026